Authors:
Shah, MR
Hasselblad, V
Stinnett, SS
Gheorghiade, M
Swedberg, K
Califf, RM
O'Connor, CM
Citation: Mr. Shah et al., Hemodynamic profiles of advanced heart failure: Association with clinical characteristics and long-term outcomes, J CARD FAIL, 7(2), 2001, pp. 105-113
Authors:
Alexander, KP
Newby, LK
Hellkamp, AS
Harrington, RA
Peterson, ED
Kopecky, S
Langer, A
O'Gara, P
O'Connor, CM
Daly, RN
Califf, RM
Khan, S
Fuster, V
Citation: Kp. Alexander et al., Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up, J AM COL C, 38(1), 2001, pp. 1-7
Authors:
Braunwald, E
Antman, EM
Beasley, JW
Califf, RM
Cheitlin, MD
Hochman, JS
Jones, RH
Kereiakes, D
Kupersmith, J
Levin, TN
Pepine, CJ
Schaeffer, JW
Smith, EE
Steward, DE
Theroux, P
Citation: E. Braunwald et al., ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) (vol 36, pg 970, 2000), J AM COL C, 38(1), 2001, pp. 294-295
Authors:
Anderson, KM
Califf, RM
Stone, GW
Neumann, FJ
Montalescot, G
Miller, DP
Ferguson, JJ
Willerson, JT
Weisman, HF
Topol, EJ
Citation: Km. Anderson et al., Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention, J AM COL C, 37(8), 2001, pp. 2059-2065
Authors:
Cantor, WJ
Hellkamp, AS
Peterson, ED
Zidar, JP
Cowper, PA
Sketch, MH
Tcheng, JE
Califf, RM
Ohman, EM
Citation: Wj. Cantor et al., Achieving optimal results with standard balloon angioplasty: Can baseline and angiographic variables predict stent-like outcomes?, J AM COL C, 37(7), 2001, pp. 1883-1890
Authors:
Bahit, MC
Topol, EJ
Califf, RM
Armstrong, PW
Criger, DA
Hasselbad, V
Betriu, A
Hirsh, J
Ardissino, D
Granger, CB
Citation: Mc. Bahit et al., Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb. (vol 37, pg 1001, 2001), J AM COL C, 37(7), 2001, pp. 2012-2012
Authors:
Bahit, MC
Topol, EJ
Califf, RM
Armstrong, PW
Criger, DA
Hasselblad, V
Betriu, A
Hirsh, J
Ardissino, D
Granger, CB
Citation: Mc. Bahit et al., Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb, J AM COL C, 37(4), 2001, pp. 1001-1007
Authors:
Greenbaum, AB
Harrington, RA
Hudson, MP
MacAulay, CM
Wilcox, RG
Simoons, ML
Berdan, LG
Guerci, A
Cokkinos, DV
Kitt, MM
Lincoff, AM
Topol, EJ
Califf, RM
Ohman, EM
Citation: Ab. Greenbaum et al., Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 492-498
Authors:
DeLong, ER
Nelson, CL
Wong, JB
Pryor, DB
Peterson, ED
Lee, KL
Mark, DB
Califf, RM
Pauker, SG
Citation: Er. Delong et al., Using observational data to estimate prognosis: an example using a coronary artery disease registry, STAT MED, 20(16), 2001, pp. 2505-2532
Authors:
White, HD
Simes, RJ
Aylward, PEG
Armstrong, PW
Califf, RM
French, JK
Granger, CB
Marschner, IC
Topol, EJ
Van de Werf, FJ
Wilcox, RG
Citation: Hd. White et al., Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial, LANCET, 358(9296), 2001, pp. 1855-1863
Authors:
Topol, EJ
Califf, RM
Van de Werf, F
Willerson, JT
Booth, J
White, H
Clayman, M
Deckelbaum, L
Lincoff, AM
Ohman, EM
Bates, E
Gibler, WB
Hochman, J
Kleiman, N
Grinfeld, L
Aylward, P
Armstrong, PW
Heikkila, J
Vahanian, A
Steg, G
Bode, C
Adgy, AAJ
Guetta, V
Ardissino, D
Savonitto, S
Bar, F
Simoons, M
Kontny, F
White, H
Sadowski, Z
Seabra-Gomes, R
Dalby, A
Betriu, A
Swahn, E
Wilcox, R
Frye, RL
Bertrand, ME
DeMets, D
Fox, KKA
Fuster, V
Lee, KL
McCarthy, C
Waller, M
Scherer, J
van de Kerkhove, A
Kukulewicz, L
Booth, JE
Del Valle, M
Hibert, D
Brannon, D
Citation: Ej. Topol et al., Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial, LANCET, 357(9272), 2001, pp. 1905-1914
Authors:
Aronow, HD
Topol, EJ
Roe, MT
Houghtaling, PL
Wolski, KE
Lincoff, AM
Harrington, RA
Califf, RM
Ohman, EM
Kleiman, NS
Keltai, M
Wilcox, RG
Vahanian, A
Armstrong, PW
Lauer, MS
Citation: Hd. Aronow et al., Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study, LANCET, 357(9262), 2001, pp. 1063-1068
Authors:
Akkerhuis, KM
Deckers, JW
Lincoff, AM
Tcheng, JE
Boersma, E
Anderson, K
Balog, C
Califf, RM
Topol, EJ
Simoons, ML
Citation: Km. Akkerhuis et al., Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention, J AM MED A, 286(1), 2001, pp. 78-82
Citation: Ma. Morse et al., The role of local institutional review boards in protecting human researchsubjects - Reply, J AM MED A, 285(21), 2001, pp. 2713-2713
Authors:
Hudson, MP
Granger, CB
Topol, EJ
Pieper, KS
Armstrong, PW
Barbash, GI
Guerci, AD
Vahanian, A
Califf, RM
Ohman, EM
Citation: Mp. Hudson et al., Early reinfarction after fibrinolysis - Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (Alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies to Open occluded coronary arteries (GUSTO III) trials, CIRCULATION, 104(11), 2001, pp. 1229-1235
Authors:
Barbash, GI
Birnbaum, Y
Bogaerts, K
Hudson, M
Lesaffre, E
Fu, YL
Goodman, S
Houbracken, K
Munsters, K
Granger, CB
Pieper, K
Califf, RM
Topol, EJ
Van de Werf, F
Citation: Gi. Barbash et al., Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies, CIRCULATION, 103(7), 2001, pp. 954-960
Authors:
Newby, LK
Ohman, EM
Christenson, RH
Moliterno, DJ
Harrington, RA
White, HD
Armstrong, PW
Van de Werf, F
Pfisterer, M
Hasselblad, V
Califf, RM
Topol, EJ
Citation: Lk. Newby et al., Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status - The PARAGON-B troponin T substudy, CIRCULATION, 103(24), 2001, pp. 2891-2896
Authors:
Jiang, W
Alexander, J
Christopher, E
Kuchibhatla, M
Gaulden, LH
Cuffe, MS
Blazing, MA
Davenport, C
Califf, RM
Krishnan, RR
O'Connor, CM
Citation: W. Jiang et al., Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure, ARCH IN MED, 161(15), 2001, pp. 1849-1856
Authors:
Shah, MR
Hasselblad, V
Gheorghiade, M
Adams, KF
Swedberg, K
Califf, RM
O'Connor, CM
Citation: Mr. Shah et al., Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy, AM J CARD, 88(9), 2001, pp. 987-993
Authors:
Birnbaum, Y
Goodman, S
Barr, A
Gates, KB
Barbash, GI
Battler, A
Barbagelata, A
Clemmensen, P
Sgarbossa, EB
Granger, CB
Califf, RM
Wagner, GS
Citation: Y. Birnbaum et al., Comparison of primary coronary angioplasty versus thrombolysis in patientswith ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram, AM J CARD, 88(8), 2001, pp. 842-847
Authors:
O'Connor, CM
Gattis, WA
Hellkamp, AS
Langer, A
Larsen, RL
Harrington, RA
Berkowitz, SD
O'Gara, PT
Kopecky, SL
Gheorghiade, M
Daly, R
Califf, RM
Fuster, V
Citation: Cm. O'Connor et al., Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS), AM J CARD, 88(5), 2001, pp. 541-546